Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 3/2018

Open Access 01-08-2018 | Original Article

Long-term endurance training increases serum cathepsin S levels in healthy female subjects

Authors: M. Sponder, C. Minichsdorfer, I.-A. Campean, M. Emich, M. Fritzer-Szekeres, B. Litschauer, J. Strametz-Juranek

Published in: Irish Journal of Medical Science (1971 -) | Issue 3/2018

Login to get access

Abstract

Background

Circulating cathepsin S (CS) has been associated with a lower risk for breast cancer in a large Swedish cohort. Long-term physical activity has been shown to have beneficial effects on the development of various cancer subtypes, in particular breast and colorectal cancers. The aim of this study was to investigate the effect of long-term endurance sport on CS levels in females.

Material and methods

Thirty-six of 40 subjects completed the study. Subjects were told to increase their activity pensum for 8 months reaching 150 min/week moderate or 75 min/week intense exercise. Ergometries were performed at the beginning and the end of the study to prove/quantify the performance gain. Blood samples were drawn at baseline and every 2 months. Serum CS levels were measured by ELISA. To analyse the change and the progression of CS, Wilcoxon rank sum and Friedman tests were used.

Results

The sportive group (performance gain by > 4.9%) showed a significant increase of CS levels from 3.32/2.73/4.09 to 4.00/3.09/5.04 ng/ml (p = 0.008) corresponding to an increase of 20.5%.

Conclusions

We could show a significant increase of circulating CS levels in healthy female subjects induced by long-term physical activity. CS, occurring in the tumour microenvironment, is well-known to promote tumour growth, e.g. by ameliorating angiogenesis. However, the role of circulating CS in cancer growth is not clear. As physical activity is known as preventive intervention, in particular concerning breast and colorectal cancers, and long-term physical activity leads to an increase of CS levels in female subjects, circulating CS might even be involved in this protective effect.

Trial registration

Clinical trial registration: NCT02097199
Literature
1.
go back to reference Sponder M, Fritzer-Szekeres M, Marculescu R et al (2016) Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease. Heart Vessel 31(10):1603–1608CrossRef Sponder M, Fritzer-Szekeres M, Marculescu R et al (2016) Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease. Heart Vessel 31(10):1603–1608CrossRef
2.
go back to reference Sponder M, Campean IA, Emich M et al (2017) Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. BMC Cardiovasc Disord 17(1):13CrossRefPubMedPubMedCentral Sponder M, Campean IA, Emich M et al (2017) Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. BMC Cardiovasc Disord 17(1):13CrossRefPubMedPubMedCentral
3.
go back to reference Sponder M, Campean IA, Dalos D et al (2017) Influence of long-term physical activity on PCSK9, HDL/LDL-C and Lp(a)—a prospective observational trial, pol. Arch Intern Med 127(7–8):506–511 Sponder M, Campean IA, Dalos D et al (2017) Influence of long-term physical activity on PCSK9, HDL/LDL-C and Lp(a)—a prospective observational trial, pol. Arch Intern Med 127(7–8):506–511
4.
go back to reference Liu L, Shi Y, Li T et al (2016) Leisure time physical activity and cancer risk: evaluation of the WHO’s recommendation based on 126 high-quality epidemiological studies. Br J Sports Med 50:372–378CrossRefPubMed Liu L, Shi Y, Li T et al (2016) Leisure time physical activity and cancer risk: evaluation of the WHO’s recommendation based on 126 high-quality epidemiological studies. Br J Sports Med 50:372–378CrossRefPubMed
5.
go back to reference Hildebrand JS, Gapstur SM, Campbell PT et al (2013) Recreational physical activity and leisure-time sitting in relation to postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 22:1906–1912CrossRefPubMed Hildebrand JS, Gapstur SM, Campbell PT et al (2013) Recreational physical activity and leisure-time sitting in relation to postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 22:1906–1912CrossRefPubMed
6.
go back to reference Patel AV, Hildebrand JS, Campbell PT et al (2015) Leisure-time spent sitting and site-specific cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 24:1350–1359CrossRefPubMed Patel AV, Hildebrand JS, Campbell PT et al (2015) Leisure-time spent sitting and site-specific cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 24:1350–1359CrossRefPubMed
8.
go back to reference Wang B, Sun J, Kitamoto S et al (2006) Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 281:6020–6029CrossRefPubMed Wang B, Sun J, Kitamoto S et al (2006) Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 281:6020–6029CrossRefPubMed
10.
go back to reference Hughes CS, Colhoun LM, Bains BK et al (2016) Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages. Part Fibre Toxicol 13:19CrossRefPubMedPubMedCentral Hughes CS, Colhoun LM, Bains BK et al (2016) Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages. Part Fibre Toxicol 13:19CrossRefPubMedPubMedCentral
11.
go back to reference Xu J, Li D, Ke Z et al (2009) Cathepsin S is aberrantly overexpressed in human hepatocellular carcinoma. Mol Med Rep 2:713–718CrossRefPubMed Xu J, Li D, Ke Z et al (2009) Cathepsin S is aberrantly overexpressed in human hepatocellular carcinoma. Mol Med Rep 2:713–718CrossRefPubMed
12.
go back to reference Gormley JA, Hegarty SM, O'Grady A et al (2011) The role of cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study. Br J Cancer 105:1487–1494CrossRefPubMedPubMedCentral Gormley JA, Hegarty SM, O'Grady A et al (2011) The role of cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study. Br J Cancer 105:1487–1494CrossRefPubMedPubMedCentral
13.
go back to reference Shi W, Ogbomo SM, Wagh NK et al (2014) The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging. Biomaterials 35:5760–5770CrossRefPubMedPubMedCentral Shi W, Ogbomo SM, Wagh NK et al (2014) The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging. Biomaterials 35:5760–5770CrossRefPubMedPubMedCentral
14.
go back to reference Sobotic B, Vizovisek M, Vidmar R et al (2015) Proteomic identification of cysteine cathepsin substrates shed from the surface of cancer cells. Mol Cell Proteomics 14:2213–2228CrossRefPubMedPubMedCentral Sobotic B, Vizovisek M, Vidmar R et al (2015) Proteomic identification of cysteine cathepsin substrates shed from the surface of cancer cells. Mol Cell Proteomics 14:2213–2228CrossRefPubMedPubMedCentral
15.
go back to reference Burden RE, Gormley JA, Jaquin TJ et al (2009) Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis. Clin Cancer Res 15:6042–6051CrossRefPubMed Burden RE, Gormley JA, Jaquin TJ et al (2009) Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis. Clin Cancer Res 15:6042–6051CrossRefPubMed
16.
go back to reference Vazquez R, Astorgues-Xerri L, Bekradda M et al (2015) Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors. Biochimie 108:101–107CrossRefPubMed Vazquez R, Astorgues-Xerri L, Bekradda M et al (2015) Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors. Biochimie 108:101–107CrossRefPubMed
17.
go back to reference Basu S, Harris H, Larsson A et al (2015) Is there any role for serum cathepsin S and CRP levels on prognostic information in breast cancer? The Swedish mammography cohort. Antioxid Redox Signal 23:1298–1302CrossRefPubMed Basu S, Harris H, Larsson A et al (2015) Is there any role for serum cathepsin S and CRP levels on prognostic information in breast cancer? The Swedish mammography cohort. Antioxid Redox Signal 23:1298–1302CrossRefPubMed
18.
go back to reference Sponder M, Campean IA, Emich M et al (2017) Long-term endurance training increases serum cathepsin S and decreases IL-6 and hsCRP levels. J Sports Sci 35(21):2129–2134CrossRefPubMed Sponder M, Campean IA, Emich M et al (2017) Long-term endurance training increases serum cathepsin S and decreases IL-6 and hsCRP levels. J Sports Sci 35(21):2129–2134CrossRefPubMed
19.
go back to reference Du Bois D, du Bois EF (1989) A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5:303–311 discussion 312-303PubMed Du Bois D, du Bois EF (1989) A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5:303–311 discussion 312-303PubMed
20.
go back to reference Small DM, Burden RE, Jaworski J et al (2013) Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization. Int J Cancer 133:2102–2112CrossRefPubMed Small DM, Burden RE, Jaworski J et al (2013) Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization. Int J Cancer 133:2102–2112CrossRefPubMed
21.
go back to reference Ward C, Kuehn D, Burden RE et al (2010) Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF. PLoS One 5 Ward C, Kuehn D, Burden RE et al (2010) Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF. PLoS One 5
22.
go back to reference Jobs E, Riserus U, Ingelsson E et al (2010) Serum cathepsin S is associated with serum C-reactive protein and interleukin-6 independently of obesity in elderly men. J Clin Endocrinol Metab 95:4460–4464CrossRefPubMed Jobs E, Riserus U, Ingelsson E et al (2010) Serum cathepsin S is associated with serum C-reactive protein and interleukin-6 independently of obesity in elderly men. J Clin Endocrinol Metab 95:4460–4464CrossRefPubMed
23.
go back to reference Jobs E, Ingelsson E, Riserus U et al (2011) Association between serum cathepsin S and mortality in older adults. JAMA 306:1113–1121CrossRefPubMed Jobs E, Ingelsson E, Riserus U et al (2011) Association between serum cathepsin S and mortality in older adults. JAMA 306:1113–1121CrossRefPubMed
24.
go back to reference Jobs E, Riserus U, Ingelsson E et al (2013) Serum cathepsin S is associated with decreased insulin sensitivity and the development of type 2 diabetes in a community-based cohort of elderly men. Diabetes Care 36:163–165CrossRefPubMed Jobs E, Riserus U, Ingelsson E et al (2013) Serum cathepsin S is associated with decreased insulin sensitivity and the development of type 2 diabetes in a community-based cohort of elderly men. Diabetes Care 36:163–165CrossRefPubMed
25.
go back to reference Liu WL, Liu D, Cheng K et al (2016) Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer. Oncotarget Liu WL, Liu D, Cheng K et al (2016) Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer. Oncotarget
26.
go back to reference Yang Y, Lim SK, Choong LY et al (2010) Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J Proteome Res 9:4767–4778CrossRefPubMed Yang Y, Lim SK, Choong LY et al (2010) Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J Proteome Res 9:4767–4778CrossRefPubMed
27.
go back to reference Narita D, Seclaman E, Ursoniu S et al (2011) Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls. Romanian J Morphol Embryol 52:1261–1267 Narita D, Seclaman E, Ursoniu S et al (2011) Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls. Romanian J Morphol Embryol 52:1261–1267
28.
go back to reference Abou-Shousha S, Moaaz M, Sheta M et al (2016) An approach to breast cancer immunotherapy: the apoptotic activity of recombinant anti-interleukin-6 monoclonal antibodies in intact tumour microenvironment of breast carcinoma. Scand J Immunol 83:427–437CrossRefPubMed Abou-Shousha S, Moaaz M, Sheta M et al (2016) An approach to breast cancer immunotherapy: the apoptotic activity of recombinant anti-interleukin-6 monoclonal antibodies in intact tumour microenvironment of breast carcinoma. Scand J Immunol 83:427–437CrossRefPubMed
Metadata
Title
Long-term endurance training increases serum cathepsin S levels in healthy female subjects
Authors
M. Sponder
C. Minichsdorfer
I.-A. Campean
M. Emich
M. Fritzer-Szekeres
B. Litschauer
J. Strametz-Juranek
Publication date
01-08-2018
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 3/2018
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-017-1693-x

Other articles of this Issue 3/2018

Irish Journal of Medical Science (1971 -) 3/2018 Go to the issue